These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 12488407)

  • 41. Effectiveness of radiation therapy for older women with early breast cancer.
    Smith BD; Gross CP; Smith GL; Galusha DH; Bekelman JE; Haffty BG
    J Natl Cancer Inst; 2006 May; 98(10):681-90. PubMed ID: 16705122
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Utility of the SEER-Medicare data to identify chemotherapy use.
    Warren JL; Harlan LC; Fahey A; Virnig BA; Freeman JL; Klabunde CN; Cooper GS; Knopf KB
    Med Care; 2002 Aug; 40(8 Suppl):IV-55-61. PubMed ID: 12187169
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment patterns among elderly patients with stage IV breast cancer treated with HER-2-targeted therapy.
    Lang K; Hao Y; Huang H; Lin I; Rogerio JW; Menzin J
    J Comp Eff Res; 2014 Sep; 3(5):481-90. PubMed ID: 25350800
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative Effectiveness of Chemotherapy Regimens in Prolonging Survival for Two Large Population-Based Cohorts of Elderly Adults with Breast and Colon Cancer in 1992-2009.
    Du XL; Zhang Y; Parikh RC; Lairson DR; Cai Y
    J Am Geriatr Soc; 2015 Aug; 63(8):1570-82. PubMed ID: 26200214
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence and Safety of Off-Label Use of Chemotherapeutic Agents in Older Patients With Breast Cancer: Estimates From SEER-Medicare Data.
    Eaton AA; Sima CS; Panageas KS
    J Natl Compr Canc Netw; 2016 Jan; 14(1):57-65. PubMed ID: 26733555
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Revisiting the Surveillance Epidemiology and End Results Cancer Registry and Medicare Health Outcomes Survey (SEER-MHOS) Linked Data Resource for Patient-Reported Outcomes Research in Older Adults with Cancer.
    Kent EE; Malinoff R; Rozjabek HM; Ambs A; Clauser SB; Topor MA; Yuan G; Burroughs J; Rodgers AB; DeMichele K
    J Am Geriatr Soc; 2016 Jan; 64(1):186-92. PubMed ID: 26782871
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adjuvant chemotherapy for elderly patients with stage I non-small-cell lung cancer ≥4 cm in size: an SEER-Medicare analysis.
    Malhotra J; Mhango G; Gomez JE; Smith C; Galsky MD; Strauss GM; Wisnivesky JP
    Ann Oncol; 2015 Apr; 26(4):768-773. PubMed ID: 25600562
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009.
    Dinan MA; Mi X; Reed SD; Hirsch BR; Lyman GH; Curtis LH
    JAMA Oncol; 2015 May; 1(2):158-66. PubMed ID: 26181015
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients.
    Renner P; Milazzo S; Liu JP; Zwahlen M; Birkmann J; Horneber M
    Cochrane Database Syst Rev; 2012 Oct; 10():CD007913. PubMed ID: 23076939
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of erythropoiesis-stimulating agents on the short-term and long-term survivals in metastatic breast cancer patients receiving chemotherapy: a SEER population-based study.
    Lai Y; Ye Z; Civan JM; Wang C; Cristofanilli M; Mu Z; Austin L; Palazzo JP; Myers RE; Yang H
    Breast Cancer Res Treat; 2015 Sep; 153(2):407-16. PubMed ID: 26264468
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A dose intensity study of FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapy and Escherichia coli-derived granulocyte-macrophage colony-stimulating factor (GM-CSF) in advanced breast cancer patients.
    O'Shaughnessy JA; Denicoff AM; Venzon DJ; Danforth D; Pierce LJ; Frame JN; Bastian A; Ghosh B; Goldspiel B; Miller L
    Ann Oncol; 1994 Oct; 5(8):709-16. PubMed ID: 7826903
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer.
    Chen J; Long JB; Hurria A; Owusu C; Steingart RM; Gross CP
    J Am Coll Cardiol; 2012 Dec; 60(24):2504-12. PubMed ID: 23158536
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potentially inappropriate medication use in older patients with breast and colorectal cancer.
    Karuturi MS; Holmes HM; Lei X; Johnson M; Barcenas CH; Cantor SB; Gallick GE; Bast RC; Giordano SH
    Cancer; 2018 Jul; 124(14):3000-3007. PubMed ID: 29689595
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB; Feuer EJ; Harlan LC; Abrams J
    J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Strategies for improving comorbidity measures based on Medicare and Medicaid claims data.
    Wang PS; Walker A; Tsuang M; Orav EJ; Levin R; Avorn J
    J Clin Epidemiol; 2000 Jun; 53(6):571-8. PubMed ID: 10880775
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment Toxicity in Elderly Patients With Advanced Non-Small Cell Lung Cancer.
    Kale MS; Mhango G; Gomez JE; Sigel K; Smith CB; Bonomi M; Wisnivesky JP
    Am J Clin Oncol; 2017 Oct; 40(5):470-476. PubMed ID: 25784564
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical and economic outcomes associated with adjuvant chemotherapy in elderly patients with early stage operable breast cancer.
    Sail KR; Franzini L; Lairson DR; Du XL
    Value Health; 2012 Jan; 15(1):72-80. PubMed ID: 22264974
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use and outcomes of adjuvant chemotherapy in older women with breast cancer.
    Giordano SH; Duan Z; Kuo YF; Hortobagyi GN; Goodwin JS
    J Clin Oncol; 2006 Jun; 24(18):2750-6. PubMed ID: 16782915
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of depression on diagnosis, treatment, and survival of older women with breast cancer.
    Goodwin JS; Zhang DD; Ostir GV
    J Am Geriatr Soc; 2004 Jan; 52(1):106-11. PubMed ID: 14687323
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcomes of irinotecan-based chemotherapy regimens in elderly Medicare patients with metastatic colorectal cancer.
    Obeidat NA; Pradel FG; Zuckerman IH; DeLisle S; Mullins CD
    Am J Geriatr Pharmacother; 2009 Dec; 7(6):343-54. PubMed ID: 20129255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.